Axiom Brain Health

Axiom Brain Health is a premier clinical research site based in Tampa, Florida, specializing in Phase II-IV neurological clinical trials. Founded in 1993 as Axiom Clinical Research of Florida, the company has over 30 years of experience conducting studies for Alzheimer's disease, multiple sclerosis, Parkinson's disease, and other neurodegenerative conditions. In January 2024, Axiom was acquired by the Global Alzheimer's Platform Foundation (GAP) to serve as a flagship research center, expanding its capacity to utilize advanced diagnostic tools like blood-based biomarkers and PET imaging. The facility provides concierge-level care to participants and is a key site for major pharmaceutical sponsors developing disease-modifying therapies.